Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway
about
Neuro-invasion by a 'Trojan Horse' strategy and vasculopathy during intrauterine flavivirus infectionEmerging roles for the non-canonical IKKs in cancerThe selectivity of protein kinase inhibitors: a further updatePI3K-independent AKT activation in cancers: a treasure trove for novel therapeuticsHarnessing systems biology approaches to engineer functional microvascular networksTBK1 protects vacuolar integrity during intracellular bacterial infection.RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingLipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF.TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformationNF-κB and cancer: a paradigm of Yin-Yang.Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials.Genomics and proteomics approaches in understanding tumor angiogenesis.Advances in targeting IKK and IKK-related kinases for cancer therapyRAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.TBK1 regulates prostate cancer dormancy through mTOR inhibition.Toll-like receptors, wound healing, and carcinogenesis.Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation.Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancerMDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradationEndosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity.IKKε and TBK1 expression in gastric cancer.Inhibitory kappa B Kinases as targets for pharmacological regulation.NF-κB as a target for pancreatic cancer therapy.The biological activity of auranofin: implications for novel treatment of diseases.Negative regulation of TBK1-mediated antiviral immunity.High-throughput transfection and engineering of primary cells and cultured cell lines - an invaluable tool for research as well as drug development.TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity.Complex Regulation Pattern of IRF3 Activation Revealed by a Novel Dimerization Reporter System.miR-200c enhances radiosensitivity of human breast cancer cells.IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis.Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) ratNon-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer.HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.A novel function of TBK1 as a target of Cdon in oligodendrocyte differentiation and myelination.Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.
P2860
Q24276687-F9D341AB-D21D-4954-AA67-FA9AA46FB80AQ24305225-4C40D92E-D95B-46BB-936D-09FF944E31E2Q24654622-D15B9998-7B5C-45DA-BBA9-96F3300A16B8Q28259003-46D8D98B-7821-4123-97EA-E73333978183Q30432197-F69A8B99-730B-445C-A78E-F4AFB21AC98BQ33276633-322A6730-355F-4778-B81B-61247D66736DQ33306326-0D799C52-AC11-4859-8C25-49F960C120EDQ33606248-2EDCD8A6-29C4-496D-AB9B-186BC3B1C08CQ34107403-009391D6-B123-4F1B-81F2-5EB3D70E7BE1Q34682122-F2E201D0-2230-451C-8DFD-311116DFC9BCQ34778203-6520D37C-7958-4400-AC43-9CB692C7C066Q35232248-86C965EE-3C35-4007-804B-D26791D31980Q36316649-FD3DF350-6E16-46F5-BC6A-05AFF4DF0DD3Q36748498-427C2C4B-6513-431B-8CD4-085E6BF808D3Q37036746-6F55F7FB-8442-4867-92E0-9E4F852A75D7Q37149065-82E93043-A7B6-4C96-8D33-5F792BECA2D5Q37162393-EA7F3C74-A250-4E5A-BDD5-03513053AC95Q37352820-A3FCB8F6-8823-4636-936F-DB2CB4846FDAQ37547038-4D45C28A-BD8E-4E5F-A92A-DADDF3AA3021Q37571441-32DA94EE-3541-4B92-BC24-52DAA53E956CQ37689443-8260E806-CB81-498B-9D71-B202201BF73BQ37693713-4CECC0B0-2EF8-466D-9C4C-A4FD2FD7117AQ37725411-BB18AE71-0F93-4F3A-B909-3C5C62B43A73Q37907354-3CA5C324-1D0E-40CD-AF8E-AE3DE64002F3Q37996435-F1FCBB47-D129-420C-AB8F-0889CF0E3CA2Q38042341-CDDD653C-84AF-4917-8F57-103B5DD29440Q38080338-9A6808C4-C980-4E0A-B84E-29D49F4284DBQ38088746-649BFF44-C407-4D13-8E25-02D73A892CF3Q38619027-1AEB63E6-5D5E-44B4-99CA-05E8BD4D6DDAQ38716879-A0DBBB64-A468-4E07-8EA8-E60D946BD3D1Q38780664-94DADB19-0104-477B-A577-D8D565F4FB03Q39275933-C066B00C-9993-447A-951D-B88278729302Q39445379-64F1CD04-4433-48A2-9E67-374C20FA936FQ39869345-4B2A8688-7EA9-4938-8E3B-21D63B3F1F7AQ40489060-19905153-B2AE-49FB-B4E4-3586B49677AFQ47681132-7FB2F507-B80D-4245-92AC-614ED908F431Q50884625-08731E22-6972-40F3-B560-5D4746884892Q51353864-AEB9A5A4-687B-4C27-AE71-473EEBA0CF94Q55437754-A827A5D0-3DD4-41EA-B423-D2AF38D61705
P2860
Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@ast
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@en
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@nl
type
label
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@ast
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@en
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@nl
prefLabel
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@ast
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@en
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@nl
P2093
P2860
P356
P1476
Identification of proangiogeni ...... ics: TBK1 and the IRF3 pathway
@en
P2093
Christian Korherr
Hendrik Gille
Ira Pastan
Johan Dixelius
Kerstin Koenig-Hoffmann
Kristi A Egland
Rolf Schäfer
Ulrich Brinkmann
P2860
P304
P356
10.1073/PNAS.0511319103
P407
P577
2006-03-06T00:00:00Z